Fecapentaene concentration and mutagenicity in 718 North American stool samples.
The fecapentaenes (FP) are the predominant fecal mutagens identified to date, but they have not been shown to be carcinogenic. Epidemiologists looking for other fecal mutagens that may be related to colorectal cancer must disentangle from their investigations the pervasive mutagenic effect of the fecapentaenes. As a first step to studying the epidemiology of fecal mutagenicity independent of fecapentaenes, we compared FP measurements and Salmonella mutagenicity assay results for 718 acetone-extracted stool samples collected from a variety of subjects in the Washington DC metropolitan areas. In this large group, 50% of mutagenic samples contained elevated fecapentaenes. Specifically, three-quarters of the samples mutagenic in TA100 contained high FP levels. In contrast, mutagenicity in TA98 was not generally explainable by fecapentaenes, suggesting that non-fecapentaene TA98 mutagenicity should be one focus of future efforts to uncover colorectal carcinogens of etiologic importance.
Schiffman
M H
MH
Epidemiology and Biostatistics Program, National Cancer Institute, Bethesda, MD 20892.
Van Tassell
R L
RL
Andrews
A W
AW
Wacholder
S
S
Daniel
J
J
Robinson
A
A
Smith
L
L
Nair
P P
PP
Wilkins
T D
TD
D005243:Feces / Q000032:analysis*; D006801:Humans; D009152:Mutagenicity Tests; D009153:Mutagens / Q000032:analysis* / Q000633:toxicity; D009656:North America; D011090:Polyenes / Q000032:analysis* / Q000633:toxicity; D012486:Salmonella typhimurium / Q000187:drug effects
D009153:Mutagens; D011090:Polyenes